nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethotoin—SCN8A—cerebellar cortex—Parkinson's disease	0.0651	0.112	CbGeAlD
Ethotoin—SCN11A—peripheral nervous system—Parkinson's disease	0.0404	0.0696	CbGeAlD
Ethotoin—SCN11A—nerve—Parkinson's disease	0.0315	0.0542	CbGeAlD
Ethotoin—SCN8A—peripheral nervous system—Parkinson's disease	0.0306	0.0527	CbGeAlD
Ethotoin—SCN8A—nerve—Parkinson's disease	0.0239	0.0411	CbGeAlD
Ethotoin—SCN10A—peripheral nervous system—Parkinson's disease	0.0205	0.0353	CbGeAlD
Ethotoin—SCN8A—hindbrain—Parkinson's disease	0.0179	0.0308	CbGeAlD
Ethotoin—SCN10A—nerve—Parkinson's disease	0.016	0.0275	CbGeAlD
Ethotoin—SCN1A—hindbrain—Parkinson's disease	0.0135	0.0233	CbGeAlD
Ethotoin—SCN2A—hindbrain—Parkinson's disease	0.0124	0.0214	CbGeAlD
Ethotoin—SCN8A—brainstem—Parkinson's disease	0.0102	0.0176	CbGeAlD
Ethotoin—SCN8A—forebrain—Parkinson's disease	0.00988	0.017	CbGeAlD
Ethotoin—SCN7A—cardiovascular system—Parkinson's disease	0.00937	0.0162	CbGeAlD
Ethotoin—SCN11A—spinal cord—Parkinson's disease	0.0084	0.0145	CbGeAlD
Ethotoin—SCN1A—brainstem—Parkinson's disease	0.00774	0.0133	CbGeAlD
Ethotoin—SCN1A—forebrain—Parkinson's disease	0.00747	0.0129	CbGeAlD
Ethotoin—SCN11A—head—Parkinson's disease	0.00747	0.0129	CbGeAlD
Ethotoin—SCN2A—brainstem—Parkinson's disease	0.0071	0.0122	CbGeAlD
Ethotoin—SCN11A—nervous system—Parkinson's disease	0.00708	0.0122	CbGeAlD
Ethotoin—SCN2A—forebrain—Parkinson's disease	0.00686	0.0118	CbGeAlD
Ethotoin—SCN11A—central nervous system—Parkinson's disease	0.00681	0.0117	CbGeAlD
Ethotoin—Phenmetrazine—SLC6A3—Parkinson's disease	0.00668	0.166	CrCbGaD
Ethotoin—SCN10A—forebrain—Parkinson's disease	0.00661	0.0114	CbGeAlD
Ethotoin—SCN8A—spinal cord—Parkinson's disease	0.00637	0.011	CbGeAlD
Ethotoin—SCN7A—head—Parkinson's disease	0.00635	0.0109	CbGeAlD
Ethotoin—SCN3A—forebrain—Parkinson's disease	0.00603	0.0104	CbGeAlD
Ethotoin—SCN9A—midbrain—Parkinson's disease	0.00573	0.00988	CbGeAlD
Ethotoin—SCN8A—head—Parkinson's disease	0.00566	0.00975	CbGeAlD
Ethotoin—SCN9A—spinal cord—Parkinson's disease	0.00559	0.00964	CbGeAlD
Ethotoin—SCN11A—brain—Parkinson's disease	0.00541	0.00933	CbGeAlD
Ethotoin—SCN1A—medulla oblongata—Parkinson's disease	0.0054	0.0093	CbGeAlD
Ethotoin—SCN8A—nervous system—Parkinson's disease	0.00536	0.00925	CbGeAlD
Ethotoin—SCN8A—central nervous system—Parkinson's disease	0.00516	0.0089	CbGeAlD
Ethotoin—SCN5A—cardiovascular system—Parkinson's disease	0.00508	0.00876	CbGeAlD
Ethotoin—SCN8A—cerebellum—Parkinson's disease	0.00505	0.0087	CbGeAlD
Ethotoin—SCN2A—medulla oblongata—Parkinson's disease	0.00495	0.00854	CbGeAlD
Ethotoin—SCN1A—midbrain—Parkinson's disease	0.00493	0.0085	CbGeAlD
Ethotoin—SCN1A—spinal cord—Parkinson's disease	0.00481	0.0083	CbGeAlD
Ethotoin—SCN7A—brain—Parkinson's disease	0.0046	0.00793	CbGeAlD
Ethotoin—SCN2A—midbrain—Parkinson's disease	0.00453	0.0078	CbGeAlD
Ethotoin—SCN4A—head—Parkinson's disease	0.00444	0.00765	CbGeAlD
Ethotoin—SCN2A—spinal cord—Parkinson's disease	0.00442	0.00761	CbGeAlD
Ethotoin—SCN3A—medulla oblongata—Parkinson's disease	0.00435	0.0075	CbGeAlD
Ethotoin—SCN1A—head—Parkinson's disease	0.00428	0.00737	CbGeAlD
Ethotoin—Tranylcypromine—MAOB—Parkinson's disease	0.00427	0.106	CrCbGaD
Ethotoin—SCN10A—spinal cord—Parkinson's disease	0.00426	0.00734	CbGeAlD
Ethotoin—SCN4A—nervous system—Parkinson's disease	0.00421	0.00725	CbGeAlD
Ethotoin—SCN8A—brain—Parkinson's disease	0.0041	0.00707	CbGeAlD
Ethotoin—Primidone—GRIK2—Parkinson's disease	0.0041	0.102	CrCbGaD
Ethotoin—SCN1A—nervous system—Parkinson's disease	0.00406	0.00699	CbGeAlD
Ethotoin—SCN4A—central nervous system—Parkinson's disease	0.00405	0.00698	CbGeAlD
Ethotoin—SCN3A—midbrain—Parkinson's disease	0.00398	0.00686	CbGeAlD
Ethotoin—SCN2A—head—Parkinson's disease	0.00393	0.00677	CbGeAlD
Ethotoin—SCN1A—central nervous system—Parkinson's disease	0.0039	0.00673	CbGeAlD
Ethotoin—SCN3A—spinal cord—Parkinson's disease	0.00388	0.00669	CbGeAlD
Ethotoin—Methylphenobarbital—GRIK2—Parkinson's disease	0.00384	0.0955	CrCbGaD
Ethotoin—SCN1A—cerebellum—Parkinson's disease	0.00382	0.00658	CbGeAlD
Ethotoin—SCN10A—head—Parkinson's disease	0.00379	0.00652	CbGeAlD
Ethotoin—SCN2A—nervous system—Parkinson's disease	0.00372	0.00642	CbGeAlD
Ethotoin—SCN9A—brain—Parkinson's disease	0.0036	0.00621	CbGeAlD
Ethotoin—SCN10A—nervous system—Parkinson's disease	0.00359	0.00619	CbGeAlD
Ethotoin—SCN2A—central nervous system—Parkinson's disease	0.00358	0.00618	CbGeAlD
Ethotoin—Primidone—CHRNA4—Parkinson's disease	0.0035	0.0871	CrCbGaD
Ethotoin—SCN2A—cerebellum—Parkinson's disease	0.0035	0.00604	CbGeAlD
Ethotoin—SCN10A—central nervous system—Parkinson's disease	0.00346	0.00596	CbGeAlD
Ethotoin—SCN3A—head—Parkinson's disease	0.00345	0.00595	CbGeAlD
Ethotoin—SCN5A—head—Parkinson's disease	0.00344	0.00593	CbGeAlD
Ethotoin—Methylphenobarbital—CHRNA4—Parkinson's disease	0.00329	0.0817	CrCbGaD
Ethotoin—SCN3A—nervous system—Parkinson's disease	0.00327	0.00564	CbGeAlD
Ethotoin—SCN5A—nervous system—Parkinson's disease	0.00326	0.00562	CbGeAlD
Ethotoin—SCN4A—brain—Parkinson's disease	0.00321	0.00554	CbGeAlD
Ethotoin—SCN3A—central nervous system—Parkinson's disease	0.00315	0.00543	CbGeAlD
Ethotoin—SCN5A—central nervous system—Parkinson's disease	0.00314	0.00541	CbGeAlD
Ethotoin—SCN1A—brain—Parkinson's disease	0.0031	0.00534	CbGeAlD
Ethotoin—SCN3A—cerebellum—Parkinson's disease	0.00308	0.00531	CbGeAlD
Ethotoin—Tranylcypromine—MAOA—Parkinson's disease	0.00299	0.0743	CrCbGaD
Ethotoin—SCN2A—brain—Parkinson's disease	0.00284	0.0049	CbGeAlD
Ethotoin—SCN10A—brain—Parkinson's disease	0.00274	0.00473	CbGeAlD
Ethotoin—Phenobarbital—GRIK2—Parkinson's disease	0.00259	0.0643	CrCbGaD
Ethotoin—SCN3A—brain—Parkinson's disease	0.0025	0.00431	CbGeAlD
Ethotoin—SCN5A—brain—Parkinson's disease	0.00249	0.0043	CbGeAlD
Ethotoin—SCN3A—Developmental Biology—NRTN—Parkinson's disease	0.00243	0.00639	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—DLG1—Parkinson's disease	0.0024	0.00633	CbGpPWpGaD
Ethotoin—SCN4A—L1CAM interactions—DLG4—Parkinson's disease	0.00237	0.00623	CbGpPWpGaD
Ethotoin—SCN2A—L1CAM interactions—DLG4—Parkinson's disease	0.00237	0.00623	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—GDNF—Parkinson's disease	0.00235	0.00618	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—NRTN—Parkinson's disease	0.00233	0.00614	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—NRTN—Parkinson's disease	0.00233	0.00614	CbGpPWpGaD
Ethotoin—SCN10A—L1CAM interactions—DLG4—Parkinson's disease	0.00228	0.00601	CbGpPWpGaD
Ethotoin—SCN1A—L1CAM interactions—DLG4—Parkinson's disease	0.00228	0.00601	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—NRTN—Parkinson's disease	0.00225	0.00592	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—NRTN—Parkinson's disease	0.00225	0.00592	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—DLG1—Parkinson's disease	0.00222	0.00584	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—NRTN—Parkinson's disease	0.00221	0.00583	CbGpPWpGaD
Ethotoin—Phenobarbital—CHRNA4—Parkinson's disease	0.00221	0.055	CrCbGaD
Ethotoin—SCN8A—Axon guidance—GDNF—Parkinson's disease	0.00215	0.00565	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—DLG1—Parkinson's disease	0.00214	0.00564	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—DLG1—Parkinson's disease	0.00212	0.00559	CbGpPWpGaD
Ethotoin—CYP2C19—Xenobiotics—CYP2D6—Parkinson's disease	0.00206	0.00542	CbGpPWpGaD
Ethotoin—SCN5A—Cardiac Progenitor Differentiation—IGF2—Parkinson's disease	0.00205	0.00539	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—DLG1—Parkinson's disease	0.00204	0.00537	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—DLG1—Parkinson's disease	0.00204	0.00537	CbGpPWpGaD
Ethotoin—CYP2C19—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00198	0.00522	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—DLG1—Parkinson's disease	0.00197	0.00518	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—DLG1—Parkinson's disease	0.00197	0.00518	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—DLG1—Parkinson's disease	0.00196	0.00516	CbGpPWpGaD
Ethotoin—Glutethimide—CYP2D6—Parkinson's disease	0.00192	0.0478	CrCbGaD
Ethotoin—CYP2C19—Xenobiotics—CYP2E1—Parkinson's disease	0.00188	0.00496	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00188	0.00495	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—GDNF—Parkinson's disease	0.00188	0.00495	CbGpPWpGaD
Ethotoin—Tranylcypromine—CYP2E1—Parkinson's disease	0.00185	0.0459	CrCbGaD
Ethotoin—CYP2C19—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00181	0.00477	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—GDNF—Parkinson's disease	0.00174	0.00457	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—HSPA8—Parkinson's disease	0.00171	0.0045	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—GDNF—Parkinson's disease	0.00167	0.00441	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—GDNF—Parkinson's disease	0.00166	0.00437	CbGpPWpGaD
Ethotoin—SCN5A—L1CAM interactions—DLG4—Parkinson's disease	0.0016	0.00423	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—GDNF—Parkinson's disease	0.0016	0.0042	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—GDNF—Parkinson's disease	0.0016	0.0042	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—DLG1—Parkinson's disease	0.00158	0.00417	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—NRTN—Parkinson's disease	0.00158	0.00416	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—HSPA8—Parkinson's disease	0.00157	0.00414	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—GDNF—Parkinson's disease	0.00154	0.00405	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—GDNF—Parkinson's disease	0.00154	0.00405	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—GDNF—Parkinson's disease	0.00153	0.00403	CbGpPWpGaD
Ethotoin—CYP2C19—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00153	0.00403	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—DLG1—Parkinson's disease	0.00151	0.00399	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—DLG4—Parkinson's disease	0.00148	0.00389	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—DLG1—Parkinson's disease	0.00145	0.00383	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—DLG1—Parkinson's disease	0.00145	0.00383	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—GRIN2B—Parkinson's disease	0.00144	0.0038	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—DLG1—Parkinson's disease	0.0014	0.0037	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—DLG1—Parkinson's disease	0.0014	0.0037	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—HSPA8—Parkinson's disease	0.0014	0.00369	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—DLG1—Parkinson's disease	0.00138	0.00364	CbGpPWpGaD
Ethotoin—SCN5A—Cardiac Progenitor Differentiation—INS—Parkinson's disease	0.00136	0.00358	CbGpPWpGaD
Ethotoin—Tranylcypromine—CYP2D6—Parkinson's disease	0.00136	0.0337	CrCbGaD
Ethotoin—SCN11A—Axon guidance—DLG4—Parkinson's disease	0.00132	0.00347	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—GRIN2B—Parkinson's disease	0.00129	0.00339	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—HSPA8—Parkinson's disease	0.00128	0.00338	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00126	0.00333	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—GDNF—Parkinson's disease	0.00124	0.00326	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00122	0.00321	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—DLG4—Parkinson's disease	0.0012	0.00317	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.0012	0.00316	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—GDNF—Parkinson's disease	0.00118	0.00312	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—ABL1—Parkinson's disease	0.00118	0.0031	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—GRIN2B—Parkinson's disease	0.00118	0.0031	CbGpPWpGaD
Ethotoin—CYP2C19—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00115	0.00303	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—GDNF—Parkinson's disease	0.00114	0.003	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—GDNF—Parkinson's disease	0.00114	0.003	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—HSPA8—Parkinson's disease	0.00112	0.00296	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—GDNF—Parkinson's disease	0.0011	0.00289	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—GDNF—Parkinson's disease	0.0011	0.00289	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—GDNF—Parkinson's disease	0.00108	0.00285	CbGpPWpGaD
Ethotoin—Phenobarbital—CYP2E1—Parkinson's disease	0.00107	0.0267	CrCbGaD
Ethotoin—CYP2C19—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00107	0.00283	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—DLG4—Parkinson's disease	0.00105	0.00277	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—ABL1—Parkinson's disease	0.00105	0.00276	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00105	0.00276	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—HSPA8—Parkinson's disease	0.00104	0.00273	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—GRIN2B—Parkinson's disease	0.00103	0.00271	CbGpPWpGaD
Ethotoin—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00101	0.00266	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—HSPA8—Parkinson's disease	0.001	0.00264	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—HSPA8—Parkinson's disease	0.000992	0.00261	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—DLG1—Parkinson's disease	0.000986	0.0026	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—DLG4—Parkinson's disease	0.000973	0.00256	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—ABL1—Parkinson's disease	0.000959	0.00253	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—HSPA8—Parkinson's disease	0.000953	0.00251	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—HSPA8—Parkinson's disease	0.000953	0.00251	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—GRIN2B—Parkinson's disease	0.000951	0.00251	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—DLG4—Parkinson's disease	0.000939	0.00247	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000932	0.00246	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—DLG4—Parkinson's disease	0.000931	0.00245	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—HSPA8—Parkinson's disease	0.000919	0.00242	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—HSPA8—Parkinson's disease	0.000919	0.00242	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—GRIN2B—Parkinson's disease	0.000917	0.00242	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—HSPA8—Parkinson's disease	0.000915	0.00241	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—GRIN2B—Parkinson's disease	0.00091	0.0024	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—DLG4—Parkinson's disease	0.000894	0.00236	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—DLG4—Parkinson's disease	0.000894	0.00236	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000885	0.00233	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—GRIN2B—Parkinson's disease	0.000874	0.0023	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—GRIN2B—Parkinson's disease	0.000874	0.0023	CbGpPWpGaD
Ethotoin—CYP2C19—Melatonin metabolism and effects—APOE—Parkinson's disease	0.000872	0.0023	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—DLG4—Parkinson's disease	0.000862	0.00227	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—DLG4—Parkinson's disease	0.000862	0.00227	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—DLG4—Parkinson's disease	0.000859	0.00226	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000855	0.00225	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000854	0.00225	CbGpPWpGaD
Ethotoin—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000844	0.00222	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—GRIN2B—Parkinson's disease	0.000843	0.00222	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—GRIN2B—Parkinson's disease	0.000843	0.00222	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—ABL1—Parkinson's disease	0.000839	0.00221	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—GRIN2B—Parkinson's disease	0.000839	0.00221	CbGpPWpGaD
Ethotoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000782	0.00206	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—ABL1—Parkinson's disease	0.000775	0.00204	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—GDNF—Parkinson's disease	0.000772	0.00203	CbGpPWpGaD
Ethotoin—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000772	0.00203	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000758	0.002	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—ABL1—Parkinson's disease	0.000748	0.00197	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—ABL1—Parkinson's disease	0.000742	0.00195	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—HSPA8—Parkinson's disease	0.00074	0.00195	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000721	0.0019	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—ABL1—Parkinson's disease	0.000712	0.00188	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—ABL1—Parkinson's disease	0.000712	0.00188	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—HSPA8—Parkinson's disease	0.000708	0.00186	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—DLG4—Parkinson's disease	0.000694	0.00183	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000693	0.00183	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—ABL1—Parkinson's disease	0.000687	0.00181	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—ABL1—Parkinson's disease	0.000687	0.00181	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—ABL1—Parkinson's disease	0.000684	0.0018	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—HSPA8—Parkinson's disease	0.00068	0.00179	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—HSPA8—Parkinson's disease	0.00068	0.00179	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—GRIN2B—Parkinson's disease	0.000679	0.00179	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—DLG4—Parkinson's disease	0.000664	0.00175	CbGpPWpGaD
Ethotoin—CYP2C19—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000657	0.00173	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—HSPA8—Parkinson's disease	0.000656	0.00173	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—HSPA8—Parkinson's disease	0.000656	0.00173	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—GRIN2B—Parkinson's disease	0.000649	0.00171	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—HSPA8—Parkinson's disease	0.000646	0.0017	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—DLG4—Parkinson's disease	0.000638	0.00168	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—DLG4—Parkinson's disease	0.000638	0.00168	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000634	0.00167	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—GRIN2B—Parkinson's disease	0.000624	0.00164	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—GRIN2B—Parkinson's disease	0.000624	0.00164	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—DLG4—Parkinson's disease	0.000615	0.00162	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—DLG4—Parkinson's disease	0.000615	0.00162	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—DLG4—Parkinson's disease	0.000606	0.0016	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—GRIN2B—Parkinson's disease	0.000601	0.00158	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—GRIN2B—Parkinson's disease	0.000601	0.00158	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—GRIN2B—Parkinson's disease	0.000592	0.00156	CbGpPWpGaD
Ethotoin—Phenobarbital—ABCB1—Parkinson's disease	0.000562	0.014	CrCbGaD
Ethotoin—CYP2C19—Biological oxidations—GSTA4—Parkinson's disease	0.000556	0.00146	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—INS—Parkinson's disease	0.000555	0.00146	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—ABL1—Parkinson's disease	0.000553	0.00146	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000548	0.00144	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—ABL1—Parkinson's disease	0.000529	0.00139	CbGpPWpGaD
Ethotoin—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000522	0.00137	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—ABL1—Parkinson's disease	0.000508	0.00134	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—ABL1—Parkinson's disease	0.000508	0.00134	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—MAOB—Parkinson's disease	0.000495	0.0013	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—INS—Parkinson's disease	0.000494	0.0013	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—ABL1—Parkinson's disease	0.00049	0.00129	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—ABL1—Parkinson's disease	0.00049	0.00129	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—ABL1—Parkinson's disease	0.000483	0.00127	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—HSPA8—Parkinson's disease	0.000461	0.00121	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—INS—Parkinson's disease	0.000452	0.00119	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—DLG4—Parkinson's disease	0.000433	0.00114	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000427	0.00113	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000426	0.00112	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—GRIN2B—Parkinson's disease	0.000423	0.00111	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP2D6—Parkinson's disease	0.000368	0.00097	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—INS—Parkinson's disease	0.000366	0.000963	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000363	0.000957	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—INS—Parkinson's disease	0.00035	0.000921	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—ABL1—Parkinson's disease	0.000345	0.000908	CbGpPWpGaD
Ethotoin—SCN7A—Axon guidance—IL6—Parkinson's disease	0.00034	0.000895	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—CYP2E1—Parkinson's disease	0.000337	0.000887	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—INS—Parkinson's disease	0.000336	0.000885	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—INS—Parkinson's disease	0.000336	0.000885	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000332	0.000875	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—INS—Parkinson's disease	0.000324	0.000854	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—INS—Parkinson's disease	0.000324	0.000854	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.00031	0.000817	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000308	0.000811	CbGpPWpGaD
Ethotoin—SCN11A—Axon guidance—IL6—Parkinson's disease	0.000303	0.000797	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—TNF—Parkinson's disease	0.0003	0.000791	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—COMT—Parkinson's disease	0.000279	0.000735	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTP1—Parkinson's disease	0.000278	0.000732	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—MAOA—Parkinson's disease	0.000277	0.00073	CbGpPWpGaD
Ethotoin—SCN8A—Axon guidance—IL6—Parkinson's disease	0.000277	0.000729	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—COMT—Parkinson's disease	0.000275	0.000725	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000274	0.000721	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—TNF—Parkinson's disease	0.000268	0.000705	CbGpPWpGaD
Ethotoin—CYP2C19—Biological oxidations—GSTM1—Parkinson's disease	0.000255	0.000672	CbGpPWpGaD
Ethotoin—CYP2C19—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000252	0.000663	CbGpPWpGaD
Ethotoin—SCN5A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.00025	0.000659	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—TNF—Parkinson's disease	0.000245	0.000645	CbGpPWpGaD
Ethotoin—SCN7A—Developmental Biology—IL6—Parkinson's disease	0.000242	0.000638	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—INS—Parkinson's disease	0.000228	0.0006	CbGpPWpGaD
Ethotoin—SCN9A—Axon guidance—IL6—Parkinson's disease	0.000224	0.00059	CbGpPWpGaD
Ethotoin—SCN11A—Developmental Biology—IL6—Parkinson's disease	0.000216	0.000569	CbGpPWpGaD
Ethotoin—SCN3A—Axon guidance—IL6—Parkinson's disease	0.000214	0.000564	CbGpPWpGaD
Ethotoin—SCN2A—Axon guidance—IL6—Parkinson's disease	0.000206	0.000542	CbGpPWpGaD
Ethotoin—SCN4A—Axon guidance—IL6—Parkinson's disease	0.000206	0.000542	CbGpPWpGaD
Ethotoin—SCN10A—Axon guidance—IL6—Parkinson's disease	0.000198	0.000523	CbGpPWpGaD
Ethotoin—SCN1A—Axon guidance—IL6—Parkinson's disease	0.000198	0.000523	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—TNF—Parkinson's disease	0.000198	0.000522	CbGpPWpGaD
Ethotoin—SCN8A—Developmental Biology—IL6—Parkinson's disease	0.000198	0.00052	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000192	0.000506	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—TNF—Parkinson's disease	0.000189	0.000499	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—TNF—Parkinson's disease	0.000182	0.000479	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—TNF—Parkinson's disease	0.000182	0.000479	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ND3—Parkinson's disease	0.000181	0.000477	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MCCC1—Parkinson's disease	0.000181	0.000477	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—TNF—Parkinson's disease	0.000175	0.000462	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—TNF—Parkinson's disease	0.000175	0.000462	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TALDO1—Parkinson's disease	0.00017	0.000448	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—OMD—Parkinson's disease	0.00017	0.000448	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	0.000161	0.000425	CbGpPWpGaD
Ethotoin—SCN9A—Developmental Biology—IL6—Parkinson's disease	0.00016	0.000421	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GCH1—Parkinson's disease	0.000154	0.000405	CbGpPWpGaD
Ethotoin—SCN3A—Developmental Biology—IL6—Parkinson's disease	0.000153	0.000403	CbGpPWpGaD
Ethotoin—SCN2A—Developmental Biology—IL6—Parkinson's disease	0.000147	0.000387	CbGpPWpGaD
Ethotoin—SCN4A—Developmental Biology—IL6—Parkinson's disease	0.000147	0.000387	CbGpPWpGaD
Ethotoin—SCN10A—Developmental Biology—IL6—Parkinson's disease	0.000142	0.000373	CbGpPWpGaD
Ethotoin—SCN1A—Developmental Biology—IL6—Parkinson's disease	0.000142	0.000373	CbGpPWpGaD
Ethotoin—SCN5A—Axon guidance—IL6—Parkinson's disease	0.000139	0.000367	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000139	0.000366	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—FBP1—Parkinson's disease	0.000137	0.000361	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—DBH—Parkinson's disease	0.000137	0.000361	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GBA—Parkinson's disease	0.000137	0.000361	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—TNF—Parkinson's disease	0.000123	0.000325	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—DDC—Parkinson's disease	0.000101	0.000265	CbGpPWpGaD
Ethotoin—SCN5A—Developmental Biology—IL6—Parkinson's disease	9.95e-05	0.000262	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTA4—Parkinson's disease	9.5e-05	0.00025	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	9.38e-05	0.000247	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	8.56e-05	0.000225	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MAOB—Parkinson's disease	8.47e-05	0.000223	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	8.06e-05	0.000212	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	6.3e-05	0.000166	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CTGF—Parkinson's disease	6.18e-05	0.000163	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	5.76e-05	0.000152	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—NQO1—Parkinson's disease	5.69e-05	0.00015	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—TH—Parkinson's disease	5.61e-05	0.000148	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—CYCS—Parkinson's disease	5.39e-05	0.000142	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—COMT—Parkinson's disease	4.77e-05	0.000126	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTP1—Parkinson's disease	4.75e-05	0.000125	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MAOA—Parkinson's disease	4.74e-05	0.000125	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—HMOX1—Parkinson's disease	4.68e-05	0.000123	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—ABCB1—Parkinson's disease	4.5e-05	0.000118	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GSTM1—Parkinson's disease	4.36e-05	0.000115	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—GPX1—Parkinson's disease	4.18e-05	0.00011	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—MTHFR—Parkinson's disease	3.86e-05	0.000102	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—APOE—Parkinson's disease	3.59e-05	9.46e-05	CbGpPWpGaD
Ethotoin—CYP2C19—Metabolism—INS—Parkinson's disease	3.07e-05	8.08e-05	CbGpPWpGaD
